Copley II: Long-term Outcome Follow-up Study of Osteoporotic Women Who Underwent a Local Osteo-Enhancement Procedure (LOEP) in the Proximal Femur
Follow-up Evaluation of Osteoporotic Women Who Underwent a Local Osteo-Enhancement Procedure (LOEP) in the Proximal Femur
1 other identifier
observational
12
0 countries
N/A
Brief Summary
To evaluate longer-term (5-7 years) outcomes of the twelve (12) subjects treated with AGN1 Femoral LOEP in the clinical study "A Prospective Pilot Evaluation of Percutaneous Osteo-supplementation in the Proximal Femur of Osteoporotic Patients". Performance will be evaluated via medical history evaluation, X-ray, DXA, CT and mobility testing. The study will look at the extent to which the benefits demonstrated in the initial, baseline study were sustained over time. In this manner, it may be possible to determine the rate of change in BMD following the treatment; thereby allowing prediction of the total benefit period. In addition, this longer period of observation allows for further evaluation of the safety profile of the material in osteoporosis patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jan 2016
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 13, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 25, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
April 15, 2016
CompletedFirst Submitted
Initial submission to the registry
January 17, 2025
CompletedFirst Posted
Study publicly available on registry
January 29, 2025
CompletedJanuary 29, 2025
January 1, 2025
1 month
January 17, 2025
January 23, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (9)
Bone Mineral Density
Bone mineral density (BMD) assessed by DXA scans (T-score ) of the treated hip compared to nontreated hip (femoral neck).
through study completion, an average of 30 days
Bone Mineral Density
Bone mineral density (BMD) assessed by DXA scans (absolute value measurement) of the treated hip compared to nontreated hip (femoral neck).
through study completion, an average of 30 days
Bone Mineral Density
Percent change compared to baseline for the treated femoral neck measurement of BMD.
through study completion, an average of 30 days
Bone Mineral Density
Percent change compared to baseline for the untreated femoral neck measurement of BMD.
through study completion, an average of 30 days
Bone Mineral Density
Bilateral hip CT scan analysis of the trabecular bone density.
through study completion, an average of 30 days
Bone Mineral Density
Bilateral hip CT scan analysis of the trabecular bone volume.
through study completion, an average of 30 days
Bone Mineral Density
Bilateral hip CT scan analysis of the cortical bone density.
through study completion, an average of 30 days
Bone Mineral Density
Bilateral hip CT scan analysis of the cortical bone volume.
through study completion, an average of 30 days
Bone Mineral Density
Bilateral hip CT scan analysis of any qualitative observations compared to baseline CT scans.
through study completion, an average of 30 days
Secondary Outcomes (4)
Subject Interview
through study completion, an average of 30 days
Subject Interview
through study completion, an average of 30 days
Subject Interview
through study completion, an average of 30 days
FRAX Index Risk Assessment
through study completion, an average of 30 days
Eligibility Criteria
Females aged 56 or older and menses have ceased for at least one year. Subjects that were participants in the original study that signed a consent form, received treatment with AGN1 Femoral LOEP and completed the original study.
You may qualify if:
- participated in the original study and signed the consent form
- received treatment with AGN1 Femoral LOEP
- completed the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- OTHER
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 17, 2025
First Posted
January 29, 2025
Study Start
January 13, 2016
Primary Completion
February 25, 2016
Study Completion
April 15, 2016
Last Updated
January 29, 2025
Record last verified: 2025-01